Sarepta Therapeutics, Inc. Earnings

Sarepta Therapeutics, Inc.’s revenue jumped 80.15% since last year same period to $744.86Mn in the Q1 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 13.13% jump in its revenue since last 3-months.

Sarepta Therapeutics, Inc.’s net profit fell -1338.98% since last year same period to $-447.51Mn in the Q1 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated -381.36% fall in its net profits since last 3-months.

Sarepta Therapeutics, Inc.’s net profit margin fell -787.75% since last year same period to -60.08% in the Q1 2025. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated -348.71% fall in its net profit margins since last 3-months.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.06 - a -91.18% fall from last quarter’s estimates.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at 0.06.

Sarepta Therapeutics, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Sarepta Therapeutics, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.